US 11046785
Compositions and methods for treatment of diabetic macular edema
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 11046785 (Compositions and methods for treatment of diabetic macular edema) held by Takeda Pharmaceutical Company Limited expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K9/0051, A61P